MYD88 and chronic obstructive pulmonary disease: Previous reports have shown that in a chronic obstructive pulmonary disease (COPD) inflammatory model, SH attenuated inflammation by reducing the mRNA levels of TLR4, MyD88, and NF-κ B p65 and the protein expression of TLR4 and p65.